Lu-Shan Yu
Overview
Explore the profile of Lu-Shan Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liu Y, Yuan L, Gao Z, Xiao Y, Sun H, Yu L, et al.
Sci Rep
. 2016 Mar;
6:23763.
PMID: 27025983
Uridine diphosphate glucuronosyltransferase 1A (UGT1A) is a major phase II drug-metabolism enzyme superfamily involved in the glucuronidation of endobiotics and xenobiotics in humans. Many polymorphisms in UGT1A genes are reported...
12.
Wang Z, Chen M, Zhu L, Yu L, Zeng S, Xiang M, et al.
Ther Clin Risk Manag
. 2015 Apr;
11:449-67.
PMID: 25848291
Background: Coprescribing of clopidogrel and other drugs is common. Available reviews have addressed the drug-drug interactions (DDIs) when clopidogrel is as an object drug, or focused on combination use of...
13.
Li L, Yao Q, Xu S, Hu H, Shen Q, Tian Y, et al.
Eur J Pharm Biopharm
. 2014 Jul;
88(3):759-67.
PMID: 24980806
Ginkgolic acids (GAs) in natural product Ginkgobiloba L. are the pharmacological active but also toxic components. Two compounds, GA (C15:1) and GA (C17:1) are the most abundant GAs. In this...
14.
Zhou Q, Yu L, Zeng S
Drug Metab Rev
. 2014 May;
46(3):283-90.
PMID: 24796860
Drug transporters and drug metabolism enzymes govern drug absorption, distribution, metabolism and elimination. Many literature works presenting important aspects related to stereochemistry of drug metabolism are available. However, there is...
15.
Chai X, Hu H, Yu L, Zeng S
Zhejiang Da Xue Xue Bao Yi Xue Ban
. 2014 May;
43(2):168-74.
PMID: 24782373
Objective: To construct the vectors of human glutathione S-transferase A1 (GSTA1), P1 (GSTP1), T1(GSTT1) genes and express in Escherichia coli (E. coli). Methods: Human GSTA1, GSTP1 and GSTT1 gene whole...
16.
Zhu Q, Yu L, Zheng G, Xie S, Tao Q
Zhejiang Da Xue Xue Bao Yi Xue Ban
. 2014 May;
43(2):164-7.
PMID: 24782372
Objective: To determine the contents of L-enantiomer impurity in valaciclovir hydrochloride. Methods: Valaciclovir enantiomers were separated and determined by using chiral high performance liquid chromatography. Chromatographic conditions were as follows:CROWNPAK(®)...
17.
Zhu Q, Yu L, Zheng G, Xie S, Tao Q
Zhejiang Da Xue Xue Bao Yi Xue Ban
. 2014 May;
43(2):160-3.
PMID: 24782371
Objective: To determine the enantiomeric impurity contents of domestic timolol maleate in bulk drugs and eye drops. Methods: Enantiomer impurity of timolol was assayed by chiral high performance liquid chromatography....
18.
Shen Q, Yu L, Zhou H, Zeng S
Zhejiang Da Xue Xue Bao Yi Xue Ban
. 2014 May;
43(2):135-40.
PMID: 24782366
Objective: To establish a HPLC method for simultaneous determination of four major constituents (madecassoside, asiaticoside, madecassic acid and asiatic acid) in Centella asiatica (L.) urban extracts. Methods: The analysis was...
19.
Gao C, Yu L, Zeng S, Huang Y, Zhou Q
Ther Clin Risk Manag
. 2014 Apr;
10:217-27.
PMID: 24707182
Background: Personalized medicine should be encouraged because patients are complex, and this complexity results from biological, medical (eg, demographics, genetics, polypharmacy, and multimorbidities), socioeconomic, and cultural factors. Levofloxacin (LVX) is...
20.
Zhou Y, Yu L, Zeng S, Huang Y, Xu H, Zhou Q
Ther Clin Risk Manag
. 2014 Jan;
10:17-26.
PMID: 24379677
Background: Coadministration of 1,4-dihydropyridine calcium channel blockers (DHP-CCBs) with statins (or 3-hydroxy-3-methylglutaryl-coenzyme A [HMG-CoA] reductase inhibitors) is common for patients with hypercholesterolemia and hypertension. To reduce the risk of myopathy,...